Chelsea To Discuss NORTHERA NDA For Treatment Of Symptomatic Neurogenic OH - NASDAQ PDF Print
NASDAQ
(RTTNews.com) - Chelsea Therapeutics International, Ltd. (CHTP) said it will meet with the Food and Drug Administration's, or FDA's, Cardiovascular and Renal Drugs Advisory Committee on February 23, 2012 to review clinical data in support of the New ...
Chelsea Therapeutics to Discuss NORTHERA(TM) (droxidopa) NDA for the Treatment

...

 
Share |
Copyright © 2025 Global Dialysis. All Rights Reserved.